News

Sjögren's syndrome is a chronic autoimmune disorder that affects millions worldwide, especially women, causing unrelenting ...
The following is a summary of “Eye as a window to oral and pain symptoms in Sjögren’s disease,” published in the April 2025 ...
Background To investigate whether certain dry eye (DE) metrics relate to oral and pain manifestations of Sjögren’s disease ...
Sjögren's syndrome (SS) is a common immune disease that mainly affects the exocrine glands, which clinically present xerostomia, keratoconjuctivitis sicca and serological autoantibodies including ...
Manipal Hospital Vijayawada has successfully diagnosed and treated a rare case of Sjögren’s Syndrome affecting the brain, a ...
Johnson & Johnson's FcRn inhibitor nipocalimab has been awarded fast-track status by the FDA as a treatment for Sjögren's disease (SjD), an autoimmune condition that affects millions of people ...
The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press release from Johnson & Johnson. The announcement comes 5 months after the ...
Johnson & Johnson JNJ announced that the FDA has granted a Fast Track designation (“FTD’) to its investigational drug, nipocalimab, for treating adult patients with moderate-to-severe Sjögren ...